Rev. sci. tech. Off. int. Epiz.. 1 9 9 8 , 1 7 (1), 351-364 Lessons from qene knockouts N.Osterrieder (1) &E. Wolf ( 2 ) (1) Institute of Molecular and Cellular Virology, Friedrich-Loeffler-lnstitute, Federal Research Centre for Virus Diseases of Animals, D-17498 Insel Riems, Germany (2| (Corresponding author) Institute for Molecular Animal Breeding/Gene Centre, Ludwig-Maximilians-University, Feodor-Lynen-Strasse 25, D-81377 Munich, Germany Summary The authors describe t h e t e c h n i q u e f o r t h e application of homologous r e c o m b i n a t i o n in e m b r y o n i c s t e m cells, w h i c h is n o w w i d e l y used t o e n g i n e e r m i c e w h i c h c a r r y s p e c i f i c k n o c k o u t s o f g e n e s . A s u m m a r y is g i v e n o f s o m e of t h e k n o w l e d g e of the pathogenesis of and resistance t o infections w i t h parasites, bacteria, or viruses w h i c h has accumulated during recent years, based o n the i n v e s t i g a t i o n o f k n o c k o u t m i c e . S p e c i a l e m p h a s i s is p l a c e d o n k n o c k o u t a n i m a l s w h i c h l a c k c o m p o n e n t s of t h e c y t o k i n e n e t w o r k , l a c k g e n e s w h i c h a r e c r i t i c a l f o r t h e c o r r e c t p r e s e n t a t i o n o f antigens o r a r e d e f i c i e n t in different i m m u n e cell s u b s e t s . In a d d i t i o n , a brief e x p l a n a t i o n is o f f e r e d of t h e possibilities f o r i n d u c i n g t a r g e t e d deletions o r m u t a t i o n s in g e n e s of livestock s p e c i e s (e.g., b y n u c l e a r t r a n s f e r o r b y m u t a g e n e s i s using" t h e alkylating a g e n t Nethyl-/V-nitrosourea) w h i c h could lead t o the breeding of animals w h i c h a r e resistant t o infectious d i s e a s e s in t h e f u t u r e . Keywords Bacteria - Cytokines - Genetics - Knockout mice - Livestock - M u t a g e n e s i s - Parasites Viruses. Gene targeting in embryonic stem cells: a powerful tool for analysing gene function Embryonic stem (ES) cells are pluripotent cell lines which are reproducibly derived from the inner cell mass of mouse blastocysts ( 2 3 , 5 8 ) . Differentiation of ES cells is inhibited by leukaemia inhibitory factor (LIF) or other cytokines of the interleukin-6 family which allow long-term culture and genetic manipulation of ES cells in vitro ( 1 0 0 , 1 0 1 , 1 0 2 ) . Upon injection into blastocysts ( 1 2 ) or aggregation with morula stage embryos ( 1 0 3 ) , ES cells may contribute to all tissues of the resulting chimera, including its germ line (Fig. 1). Therefore, the possibility exists - at least indirectly to reconstitute mice from cultured cells. The need to produce chimeras can be circumvented by aggregating ES cells with tetraploid embryos ( 6 2 ) . Using this technique, researchers have obtained completely ES cell-derived offspring: however, these were not fertile and thus not suitable to establish transgenic lines. ES cell technology is now widely established and offers a powerful tool for functional analysis of genes. Based on the principle of homologous recombination ( 1 9 ) , various strategies have been developed to introduce targeted mutations into ES cells (36) (Fig. 2 ) . Although the efficiency of homologous recombination was low in early experiments, the frequency of targeted integration was markedly increased by using isogenetic DNA for the construction of targeting vectors (87). Initial studies were directed principally towards a complete inactivation of gene function to evaluate the biological relevance of the respective genes ( 1 3 , 14). The production and use of these so-called 'gene knockouts' and the corresponding knockout mice are now standard techniques in many laboratories. In the past few years, new methods have widened the spectrum of ES cell technologies by allowing the introduction of subtle site-directed mutations, large chromosomal alterations and tissue-specific gene knockout and repair. This allows analysis of gene function in a lineage-specific way and also permits the analysis of genes which lead to embryonic lethality if inactivated in early embryonic development (69). The most widely used system 352 Rev. sci. tech. Off. int. Epiz., 17 (1) Fig. 2 Strategies for introducing targeted mutation into the genome of embryonic stem cells The thick line represents the vector homology to the target locus; the broken line represents the bacterial plasmid. The hatched rectangles are exons. The positive selection marker is the neomycin phosphotransferase (neo) gene. The thymidine kinase (TK)gene of herpes simplex virus is used as a negative selection marker a) Replacement vector: the positive selection marker interrupts the target homology b) Insertion vector: a positive selectable marker may be cloned into the homologous sequences or the vector backbone. A double strand break is generated in the target homology prior to transfection scrapie agent ( 1 7 ) . With the second approach, the immune response of the host to different pathogens can be investigated by interfering with the immune system and by targeted disruption or modification of genes which are involved in immune mechanisms (Fig. 3 ) . Knockout animals Fig. 1 Schematic illustration of the production of germ-line chimeric mice by morula aggregation or blastocyst injection for introducing these fine-tuned mutations in mice is the Cre/lox-P system from bacteriophage Pl ( 4 4 ) . This repertoire of methods has been used extensively to dissect the functions of genes involved in complex biological systems, including those relevant for the immune system and for resistance or susceptibility to infectious diseases. Targets for gene disruption to investigate the pathogenesis of infectious diseases To investigate the molecular pathogenesis of infectious diseases and combat infectious diseases by breeding measures, two different approaches can be followed. In the first approach, the aim of generating transgenic or knockout animals can be to prevent attachment, entry or replication of the infectious agent into the respective hosts. The most striking example of this approach is the generation of P r P knockout mice which are resistant to infection with the c Discruption of receptors for infectious agents or proteins that are responsible for the development of disease Interference with the host immune system, for example by disrupting cytokine, major histocompatibillity complex or receptor genes Fig. 3 Possible target genes for the generation of knockout animals to study the pathogenesis of infectious diseases To date, few reports and applications have dealt with the prevention of entry of infectious agents into knockout animals. This is largely due to the fact that the molecular mechanisms involved in the early stages of infection of most infectious pathogens remain unclear, and the lack of information on these processes prevents the targeted disruption of genes and gene products which would prevent initial infection. However, as knowledge about the immune system in man and animals has increased significantly during the last years, the interaction of individual components of the immune system, both on the level of the immune cells and the soluble mediators which regulate the immune cascade (cytokines and chemokines, as well as cytokine and chemokine receptors) with pathogens was addressed using knockout technology. Figure 4 gives a schematic overview of 353 Rev. sci. tech. Off. int. Epiz., 17 (1) Ig : immunoglobulin APC : antigen-presenting cell TCR : T-cell receptor Fig. 4 Schematic illustration of the cytokines produced by different cells of the immune system Black arrows Indicate the differentiation or activation of cells. Dashed arrows indicate positive feedback mechanisms, arrows marked with || indicate inhibitory effects. Grey arrows indicate the cytokines produced by different cells the current knowledge of the immune system and the regulatory and modifying mechanisms underlying the defence against infectious agents. As different infectious agents are encountered by different immune measures of the host, the first goal of targeted inactivation of genes is to determine which factors in the complicated immune network have essential, beneficial or detrimental effects on the capacity of the host to control an infectious agent and the disease caused by the pathogen. Virtually all molecules involved in the immune network can be a target of gene disruptions. However, depletion of single chemokines or chemokine receptors, for example, may cause a general breakdown of the immune system, might be compensated by other related mechanisms, or may have specific effects on individual infectious pathogens ( 4 7 ) . The following description of selected reports represents examples of knockout animals which were used to address specific questions of the interaction of the host with infectious agents. cytokine activities upon infection and of the interactions of individual cytokines during acute or chronic infectious disease has been obtained, at least in widely used mouse models of infectious diseases (see below and Table I). In addition, a large number of regulatory pathways underlying the maturation of immune cells and their direction to the active sites of the immune defence has been elucidated ( 2 5 , 40). One of the most important issues in using knockout models is the understanding of the genetic basis for resistance or susceptibility to infectious diseases. This has become an issue of major interest in disease control and for the rational design of novel vaccine approaches, which are extremely important in a time of increasing numbers of immunocompromised individuals. Hence, knockout models are used to more precisely define: - the mechanisms underlying acute and chronic disease - the clearance of the pathogen from the organism - immunity to infection or at least disease. Lessons from knockouts: the mouse as a model As stated above, considerable progress has been made during recent years in identifying mammalian genes and gene products that influence the outcome of disease after infection with different agents, including parasites, bacteria and viruses. By using knockout technology, a better understanding of the In acknowledging and using the great advantages of transgenic and knockout models, however, it must be also noted that pathogenesis and immunity models of animal or human infectious diseases which rely on the use of knockout animals must be substantiated by other experimental procedures. This restriction of transgenic or knockout animals is caused by the existence of subtle feedback mechanisms in the organism which are influenced by targeted gene Rev. sci. tech. Off. int. Epiz., 17 (1) 354 Table I Examples of mice with targeted deletions of cytokine or cytokine receptor (R) genes, and infected with parasites, bacteria or viruses Targeted deletion Treated/infected with Comments IL-1 p Lipopolysaccharide Influenza virus Escherichia coli Lipopolysaccharide Lower body temperature Higher mortality Partial resistance to challenge Resistance to challenge Breakdown of self-tolerance IL-1 PR IL-2 IL-3R IL-4 IL-5R IL-10 TNF-a TNF-aR IFN-y ÍFN-yR It TNF . IFN GM-CSF Th2 : : : : : References 24, 50 1 1 40 Effect on GM-CSF and IL-5; reduced eosinophilic counts Nippostrongylus brasiliensis Toxoplasma gondii Leishmania donovani/L. mexicana Plasmodium chabaudi Trypanosoma brucei brucei Higher mortality rates Different disease progression Reduced Th2-associated cytokines Strain-dependent higher parasitemia See IL-3R Trypanosoma cruzi T. gondii Listeria monocytogenes £ coli L. monocytogenes Lower parasite burden but earlier mortality Lethal immune response Impaired resistance and clearance Mild effect Impaired resistance and clearance T. gondii t. donovani Legionella pneumophila Influenza virus Mouse hepatitis virus Herpes simplex virus Murine y-herpesvirus Lymphocytic choriomeningitis virus Plasmodium berghei L. monocytogenes Influenza virus Earlier mortality Uncontrolled visceral infection Development of persistent disease No effect No effect on central nervous system spread Enhanced suceptibility to lesions Mild effect No virus clearance in persistently infected mice No cerebral malaria Higher IL-4 production and susceptibility to disease High virus burden 63 67 72 93, 94 3,4 42 33 65 1 65 73,74 86 38 34 51 106 71 89 70 83 43 interleukin tumour necrosis factor interferon granulocyte macrophage colony-stimulating factor Thelper 2 disruption or expression, and also by the nature of any knockout and transgenic models which are very contrived per se (9, 54). The second important restriction relates to the fact that the information obtained is so far mainly restricted to the mouse, which is used as a model for many infectious diseases. The next paragraphs list some of the recent findings on the outcome of disease after infection experiments with different pathogens which have been elucidated using knockout mice. The presented data will mainly concentrate on protozoan, bacterial and especially virus diseases. Resistance to infection with parasites Parasitic infections have become a major issue world-wide. This is partially - though not exclusively - caused by the growing number of individuals who suffer from immunosuppressions. Of particular importance in the generation of an immunocompromised state in man are infections with human immunodeficiency virus type 1 (HIV-1) and also allergic diseases, whereas in animals there is a variety of causes of immunocompromised individuals. Human infections with different protozoan pathogens such as Eimeria spp., Plasmodium spp., Leishmania major, Trypanosoma spp., Toxoplasma axe. also of great concern. gondii or Pneumocystis carimi Research which applies the use of knockout animals to investigate the outcome of disease with these pathogens has concentrated on the beneficial or harmful effects of cytokine action. An infection with T. gondii can cause an acute or latent infection. Acute infections are caused by rapidly dividing tachyzoites which harm virtually every cell of the body, whereas latent infection is characterised by dormant bradyzoite forms in tissue cysts ( 3 0 ) . With regard to the molecular pathogenesis of T. gondii infection, there has been speculation that infection is controlled primarily by cell-mediated immune responses and interferon-y (IFN)-Y activity ( 8 2 ) . The effect of IFN-y was thought to be augmented by the effects of interleukin-12 (IL)-12 ( 3 2 ) . By using IFN-y knockout mice, Scharton-Kersten et al. have shown, however, that parasite control depends on IFN-y alone and that in the absence of the cytokine, tachyzoite replication is unlimited ( 7 3 , 7 4 , 7 5 ) . In contrast, IL-12 was produced to levels found in wild-type mice, thus demonstrating an indirect function of IL-12 through IFN-y in control of T. gondii infection, since the infection could not be 355 Rev. sci. tech. Off. int. Epiz, 17 (1) controlled by IL-12 alone. Mice which no longer expressed the IFN-y regulatory factor 1 (IRF-1) gene and which, as a consequence, were unable to produce nitric oxide (NO), the potent inactivator of intracellular (macrophage) parasites, were more susceptible to infection, although NO was not exclusively responsible for clearance of the pathogen (48). In mice which were devoid of another cytokine, IL-10, T. gondii infection. instantly caused high mortality which was characterised by increased levels of IFN-y and IL-12. In addition, other key cytokines, such as I L - 1 b and tumour necrosis factor a (TNF-a) were augmented, which suggests that the modifying cytokine IL-10 regulates other cytokines and that in the absence of IL-10, IFN-y and IL-12 cause a C D 4 (cluster of differentiation antigen) T-cell-dependent immunopathological disease ( 3 3 ) . These findings were substantiated by studies which analysed IL-4-deficient mice and their susceptibility to T. gondii infection ( 6 7 ) . IL-4 knockout mice produced significantly lower levels of IL-10 but higher levels of IFN-y, and mortality rates were greatly enhanced. + Infections of animals or man with Trypanosoma cruzi (Chagas' disease) and T. brucei lead to disturbance of the host immune response and are characterised by an unspecific activation of the immune system, which finally results in autoimmune reactions and pathological consequences ( 1 5 , 3 5 ) . Resistance to disease has long been known to depend on IL-10 production and its suppression of IFN-y production, and infection is known to be aggravated by IFN-y (4, 6 0 ) . Using mice which were deficient in IL-10, infection with T. cruzi could be shown to lead to earlier and higher mortality, although the parasite burden was lower when compared with wild-type mice ( 4 2 ) . The same observation was made after infection of mice lacking y ò T cells (a lymphocyte subclass which is stimulated by IFN-y and downregulated by application of IL-10) ( 5 2 ) , or by using mice which were deficient in C D 4 or C D 8 cells (85). These results suggest a complex interaction between immune cells in the control of infection and their interdependence in parasite clearance and disease outcome. IFN-y knockout mice displayed higher resistance to T. brucei infection ( 4 ) , thus indicating that the regulation of and mediation by this key cytokine ( T h l helper cell activation) plays a dominant role in susceptibility and resistance to infection with Trypanosoma spp. + + + Other parasites of growing importance are L donovani and L. major. These parasites cause leishmaniosis, a proliferative and necrotic disease of the skin and inner organs which is controlled primarily by the action of IFN-y and by a T helper 1 ( T h l ) type immune response (61, 6 6 , 8 0 ) . The knowledge of Leishmania pathogenesis and the control of infection by different types of immune cells and cytokines is largely based on the use of knockout animal models and subsequent infection experiments. In the absence of T h l cells and IFN-y, macrophages which are responsible for parasite clearance are not activated and protozoan replication is unrestricted ( 5 5 , 96, 9 7 ) . Recent work, however, demonstrated that L. major pathogenesis is not enhanced if major histocompatibility complex (MHC) class II presentation is hampered in mice that lack the invariant chain. Obviously, cytokines such as IL-12 and IL-4 were able to induce maturation of T cells in the absence of functional MHC class II molecules, such that IFN-y is secreted (16). These results were confirmed and extended by the use of IFN-y knockout mice in which a TNF-a-dependent action of IL-12 in the control of leishmaniosis could be demonstrated (86). Experiments comparable to those described above on the role of yò T cells for T. cruzi have been performed with mice lacking different immune cell subsets using the protozoan parasites Eimeria spp. and Plasmodium spp. Mice which no longer expressed either ct|3 or yò T cells exhibited increased susceptibility to intestinal infection with Eimeria spp., although this appears to be due to different mechanisms: the lack of a | 3 T cells resulted in a reduced immunity to reinfection, whereas lack of y ô T cells led to enhanced intestinal damage ( 6 8 ) . As a result of B-cell depletion by knockout technology, enhanced resistance to acute Plasmodium spp. infection could be demonstrated. This appears to be due to a rise in y ò T cells. In addition, a rise in a | 3 T cells could be demonstrated in B-cell-deficient animals, although this rise was not as marked as that in the y ô subset (91). The authors conclude that this T-cell subset is largely controlled by B-cell action, that this activation is independent of IL-10 production, and that the expansion of y ô T cells might be a target for further vaccine strategies which are able to stimulate specifically this T-cell subset. + + + + + + + + + Taken together, the reports summarised above have largely improved the understanding of protozoan infection, and have revealed a complex concert of cytokines in control of resistance to and progression of infection. Thus, these findings will no doubt be useful in future attempts to generate a new generation of anti-parasitic drugs and efficacious vaccines. Resistance to disease caused by bacteria By generating transgenic and knockout animals, the pathogenesis of a variety of bacterial diseases has been elucidated. The role of B- and T-cell subsets and/or individual cytokines involved in the resistance or susceptibility to bacterial disease has been assessed, and special emphasis was put on the molecular mechanisms underlying sepsis and clearance of intracellular bacteria. Sepsis caused by gram-negative bacteria is one of the most important causes of mortality after surgical intervention, and is caused by a shock syndrome which follows lipopolysaccharide (LPS) or endotoxin release ( 1 0 , 21). A critical step in the development of LPS-caused shock is the release of the key cytokines T N F - a and IL-1(3, which cause the attraction and stimulation of immune cells locally in the micro-environment. However, the same cytokines are able to induce responses which are indicative of septic shock, not in their paracrine but in their systemic functions ( 2 0 , 2 7 ) . The 356 Rev. sci. tech. Off. int. Epiz., 1711) resistance to T N F - a - and IL-lp-induced shock was tested after application of Escherichia coli or endotoxin in respective knockout mice. Animals deficient in either cytokine were shown to exhibit increased resistance to intravenous application of endotoxin, thus indicating that acute and systemic reaction and activation of immune T cells is suppressed. In addition, in the absence of IL-1(3, LPS-induced fever is no longer observed. Hence, this mechanism plays a major role in disease progression ( 1 , 5 0 ) . Similarly, mice deficient in CD14 (which serves as a receptor for LPS) are much more resistant to the shock syndrome caused by gram-negative bacteria, as shown in an infection model. In addition, CD14-negative mice exhibited reduced levels of bacteraemia, which suggests that the spread of gram-negative bacteria at least is controlled by a CD14-dependent mechanism ( 3 7 ) . The knowledge of the early interaction of gram-negative bacteria with the host immune response could be beneficial in the treatment or immune prophylaxis against these pathogens, which are a frequent cause of mortalities in the human and animal populations. Most other reports on the genetic resistance to bacterial infections have dealt with organisms which replicate intracellularly or which interfere with host cells other than by endo- or exotoxin production. Among the bacterial infections which were analysed using knockout animals are those with Listeria spp., Brucella spp., Mycobacterium spp. or Francisella tularensis. The deletion of the (32-microglobulin gene leading to an absence of a functional CD8-dependent cytotoxicity, and also the deletion of functional C D 4 cells, were shown to cause delayed clearance of both Listeria monocytogenes and Mycobacterium bovis bacillus Bilié-Calmette-Guérin (BCG) from infected animals. However, infection with either bacterium was not fatal in these animals, thus suggesting a certain redundancy in the host response to the pathogens (46, 47). The disruption of the IFN-y receptor gene led to decreased levels of TNF-a, and Listeria infection was more severe when compared with that in control mice. Obviously IL-4, which is not measurable after L. monocytogenes infection in wild-type mice but which is produced by mice which lack the IFN-y receptor, is responsible for the more severe symptoms. In contrast, IL-12 did not appear to be involved in Lisieria-caused disease (83). Using mice which are deficient in the macrophage type I and II class A scavenger receptors (proteins which are involved in binding of bacteria), disease after infection with L. monocytogenes was shown to be augmented, which demonstrates that receptor-mediated incorporation and presentation of the antigens by macrophages is essential in the host defence against intracellular pathogens (81). + In similar animal models (i.e., using mice with MHC class I or II knockouts), researchers were able to demonstrate that Brucella abortus clearance and resistance to disease is caused mainly by the cytotoxicity of C D 8 T cells (79). By identifying the host effectors and the targets in the bacterium, the authors intend to produce rationally designed novel vaccines against + this zoonotic pathogen. Using animals which are deficient in different T-cell subsets, the resistance and immunity to F. tularensis infection was analysed. The antibacterial response was shown to be based mainly on a | 3 T cells, whereas depletion of C D 4 cells or y ô T cells did not alter disease control appreciably. The authors concluded that in general, resistance to intracellular bacteria is largely dependent on the a(3 T-cell subset, but that C D 4 or C D 8 cells can control the disease alone and independently (105). + + + + + + IFN-y knockout mice have been used to analyse the outcome of infection with Legionella pneumophila. These experiments demonstrated that IFN-y action is essential for clearance and control of pulmonary infection with Legionella. The antimicrobial activity of IFN-y after infection with this pathogen appears to be dependent on the synthesis of the inducible nitric oxide (NO) synthetase, which is upregulated by IFN-y and which is obviously responsible for intracellular killing of the bacterium which prevents systemic spread of Legionella to virtually all tissues (38). Resistance to virus infection and disease Recently, intensive research concerning the resistance to infection or disease caused by infectious pathogens has been performed with viruses. This is probably caused by the nature of the pathogens which - due to their relatively small genomes - are well characterised on a molecular basis. As a consequence, unlike the situation with more complex organisms (e.g., parasites or bacteria), a pathogen-caused effect can often be reduced to one or few viral gene products, and thus the 'choice' of transgenic or knockout animal models is facilitated. A large number of reports on genetic resistance to viral disease have been based on the analysis of knockout animals: a small and non-representative collection of this research will be presented below. Most reports concerning the effect of targeted knockouts and their influence on the outcome of disease deal with the role of different immune cell subsets, of antigen presentation by either MHC class I or II, and of individual cytokines as described above for protozoan and bacterial infections. The use of C D 4 - / - and C D 8 - / - mice and infection with influenza viruses demonstrated that neither cell type appears to be required for the clearance of the virus at the effector stage (22). In addition, the same authors could demonstrate by the use of J-chain knockout mice (which are no longer capable of forming secretory multimeric immunoglobulin A [IgA]) that immunity to influenza is not dependent on the presence of secretory IgA. Mice lacking mature B cells after the deletion of the Ig p chain also did not alter appreciably the efficiency of immune responses to influenza viruses, or the generation and maintenance of helper T cells ( 9 0 ) . In contrast, mice which are deficient in the key cytokine IL-1 exhibited higher mortality rates after infection, which were apparently caused by the inability of these animals to develop fever (50). + + 357 Rev. sci. teck Off. int. Epiz.. 17 (1) In the well-defined lymphocytic choriomeningitis virus (LCMV) system, which represents a member of the Arenaviridae, various reports on the use of knockout animals and the effects on disease resistance have been published. In MHC class I-deficient mice, no C D 8 T-cell response is observed, which in turn leads to an increased expansion of C D 4 T cells that exhibit cytotoxic activity. Therefore in wild-type animals, the C D 8 T cells appear to control C D 4 T cells and thus the resistance to disease (92). In addition, by the depletion of C D 4 T cells, an exhaustion of the immune system to LCMV could be demonstrated, in that long-term virus loads were uncontrolled in MHC class Il-knockout mice - in contrast to the clearance of acute virus loads - which was at least partially caused by the absence of cytotoxic T lymphocyte (CTL) memory cells ( 5 9 , 8 8 ) . In the context of the co-operative effect of different immune cells in LCMV control, the interaction of CD40 and CD40 ligand (CD40L) was addressed by the use of CD40 or CD40L knockout mice. The results demonstrated that the CD40-CD40L interaction is important in the interaction between B and T cells, but is far less important in T-cell activation. This is due to a failure of CD40- and CD40L-deficient animals to perform a switch in Ig isotypes and to generate antibody to T-cell-dependent antigens ( 6 4 ) . Furthermore, the presence of C D 8 cells is absolutely critical in both the acute and chronic clearance of LCMV infection, as has been demonstrated by the use of |32-microglobulin knockout mice (5, 5 9 ) . This higher susceptibility of animals to LCMV is dependent on the production of IFN-y and subsequent virus clearance by the induced C D 8 cytotoxic T cells ( 8 9 ) . These results are supported by the findings of Walsh et al., who showed the inability of perforin-deficient mice to clear LCMV because they are unable to eliminate infected cells. This inability to clear LCMV-infected cells is even potentiated in the absence of FAS-mediated apoptosis ( 5 6 , 9 5 ) . Thus, two complementary cytotoxic mechanisms are used in the elimination of LCMV from infected cells and for the resistance to particularly long-term infection. + + + + + + + An important infection of neonates is rotavirus diarrhoea, which causes damage to the gastrointestinal tract. However, immunity to rotaviruses is poorly understood. By using (32-microglobulin knockout mice, researchers demonstrated that acute virus infection can be cleared in the absence of CTL responses and that CTL are not necessary for the development of a sustainable immunity. In contrast, as shown by the use of B-cell-deficient mice, immune B cells play a major role (probably by the generation of IgA) in the clearance of acute rotavirus infection and longevity of immunity (28). Recently, these findings were corroborated by the same authors and defined more precisely: using perforin-, FAS-, and IFN-y-deficient mice, no increased susceptibility to rotavirus infection was observed, although C D 8 cells appear to be involved in virus clearance from the body by a mechanism that is independent from their cytotoxic activity (29). + Coxsackie viruses, which are members of the genus Enterovirus of the family Picornaviridae, can cause fatal heart disease, especially in immunocompromised individuals, as a result of acute or chronic myocarditis. The question of whether direct virus effects or immunopathological processes cause the diseases associated with the virus is unresolved. Knockout mice which were deficient in C D 4 cells or |32-microglobulin were shown to be less susceptible to acute disease. In addition, it could be clearly demonstrated that, although high virus titres in mouse hearts post infection were observed after C D 8 cell depletion, these mice recovered earlier from infection and death rates were markedly reduced (39): the same results were seen in mice with a targeted deletion of the T-cell tyrosine kinase ( 5 3 ) . Thus, Coxsackie virus damage to the heart appears to be largely dependent on immunopathological mechanisms, although following knockout of the IFN-y receptor, a high susceptibility to acute infection, which is caused by the absence of any inducible NO synthetase - a prerequisite for clearance of intracellular pathogens, especially in antigen-presenting cells - could be observed (53). + + Some information on HIV-1 pathogenesis and immunity has been obtained using knockout mice and murine leukaemia viruses as a model virus-host system for human infection. In the absence of B cells, initial virus replication was diminished. This reduction in virus replication is probably due to the absence of the primary target cells, which consequently leads to a reduced virus burden and T-cell and macrophage infection ( 4 9 , 7 6 ) . Further work identified C D 8 cells as the main effector cells in the resistance to mouse acquired immune deficiency syndrome (AIDS), which is at least partially dependent on perforin function. However, in both ^-microglobulin and perforin knockout mice, no progression to lymphoproliferation was observed, thus suggesting that other mechanisms besides C D 8 T-celldependent cytotoxicity are involved in resistance of the animals to the retrovirus (84). Recently, the myeloencephalopathy which is caused by murine leukaemia virus, and which is characterised by a paralysis and neurodegenerative disease indistinguishable from that caused by prions, has been shown to be independent of the absence or presence of the P r P protein. These results suggest that, although clinically and histologically similar diseases are observed after infection with either prions or murine leukaemia virus, the two agents act in different ways. Some scientists have speculated that murine leukaemia virus might use the same pathway as prions but interfere at a point downstream of the P r P (45). + + c c A relatively large number of reports on the use of knockout animals deals with the pathogenesis of and immunity to herpes simplex virus type 1 (HSV-1). Despite the intensive and thorough characterisation of this virus, the pathogenesis of herpetic lesions, latency and the short duration of immunity are less well defined. Using knockout animals and a murine model of HSV-1 infection, some revelations on the cytokines and the subsets of immune cells which are involved Rev. sci. tech. Off. int. Epiz., 17 (1) 358 in the control of infection have been obtained. Results demonstrated that in the absence of C D 4 cells - in contrast to the absence of C D 8 cells - a marked increase in susceptibility to herpetic lesions was evident (57). These results confirmed and extended previous observations that cytotoxic C D 4 cells are primarily responsible for the control of HSV-1, especially in neuronal tissues. However, the absence of TFN-y, which was drought to play a major role in the pathogenesis of ocular lesions, did not alter the disease appreciably. The findings showed that IFN-y is involved in virus clearance but that other cytokines and immune responses are also functionally active in HSV-l-caused disease ( 1 1 , 1 0 6 ) . Nonetheless, IFN-y-deficient mice were able to develop sustainable anti-HSV-l immune responses (106), which agrees with the complex cascades that orchestrate anti-HSV-1 immunity. + + + elimination have been elucidated. Tumourigenesis has been shown to be essentially dependent on cell cycle progression and on the failure of apoptotic mechanisms induced by several independent pathways. In addition, the suspected involvement of the double-stranded RNA-dependent protein kinase induced by type I interferons in tumour suppression could not be confirmed (77, 7 8 , 1 0 4 ) . Targeted mutagenesis of genes in species other than the mouse Although a number of ES cell-like cell lines have been reported in species other than the mouse, successful germ-line transmission of these cells has not been proven for any of these species (2, 3 1 ) . However, recent progress in cloning Although the use of knockout animals in carcinogenesis studies is widely accepted and has improved the understanding of different effector and immune mechanisms, few reports on virus-induced cancer and the use of knockout models are available. Mouse mammary tumour virus (MMTV)-ras transgenic animals which lack the tumour suppressor p53 were affected with tumours earlier than control mice. Using this model, it could be demonstrated that p53 can act in an apoptosis-independent manner in the elimination of tumour cells ( 4 1 ) . The absence of C D 4 or C D 8 cells led to a higher incidence of polyomavirus-induced tumours, which was even higher in C D 4 C D 8 double knockout animals (7, 8 ) , thus indicating that both classes of immune T cells play important and interdependent roles in the control of virus infection and tumourigenesis. By using different knockout animals and models of tumour induction by viruses or viral gene products, several mechanisms underlying the progression of tumour cells or their + + + + animals by nuclear transfer offers new strategies for targeted mutagenesis of genes in livestock species. Potential practical uses of nuclear transfer in livestock species include both the multiplication of embryos produced from selected matings and the ability to produce offspring from cells which can be maintained in culture prior to embryo reconstruction, thereby providing a route for precise genetic modification. The latter approach appears to be feasible in the future, as live offspring have been obtained from sheep following nuclear transfer from cell lines of embryonic (18, 98), foetal and even adult origin ( 9 9 ) (Fig. 5 ) . Whether this technology can be transferred to other species remains to be shown: however, successful cloning in calves using cultured cells from the inner cell mass of blastocysts as nuclear donors seems promising (26). These attempts may provide the possibility to generate livestock with resistance to different diseases. Fig. 5 Diagram showing the cloning of embryos by nuclear transfer using embryonic cells or cell lines established from embryonic, foetal or adult tissues Rev. sci. tech. Off. int. Epiz., 17 (1) 359 Fig. 6 Depiction of the systematic screening for new genes and their functions after ethylnitrosourea mutagenesis of mice Complementary approaches for the discovery of genes relevant for infectious diseases - ENU induces mutations. The mutants gain-of-function and complete loss-of-function mutants can also be expected. The The most important tool to obtain insight into the biological function of genes is the use of mutants. The use of ES cells and homologous recombination allow the systematic production of mouse mutants for any gene which has been cloned. Complementary to such a 'gene-driven' approach, 'phenotypedriven' approaches will be necessary to identify new genes or gene products through a search for new mutants with specific defects, for example in immune function and resistance to infectious diseases. mainly point produced will therefore be mainly hypomorphic, although systematic production and analysis of ENU mutants involves a number of different steps (Fig. 6 ) . F males of an 0 inbred strain are treated with ENU and, after a transient period of sterility, are bred with females of the same genetic background to produce F 1 pedigrees. F x and F 3 offspring and subsequently F 3 mice are scored phenotypically for dominant and recessive mutations, respectively. Once a mutant has been confirmed phenotypically and genetically, the chromosomal location of the mutation can be mapped using mice from an outcross/backcross panel produced with another inbred strain by genome-wide microsatellite-typing of Mutagenesis of mice using the alcylating agent ethylnitrosourea (ENU) is a powerful approach for the systematic production of mouse mutants for a number of reasons, as follows (6); - Protocols are available which allow a very efficient mutagenesis rate in mice. The frequency of mutant recovery is about 1/1,000 for a specific locus which can be scored phenotypically, although strain as well as dosage and treatment regimens do influence the mutagenesis rate. 'mice showing versus mice not showing' the particular phenotype. Mutations induced by ENU will not be tagged molecularly. Although this is initially a disadvantage with respect to the cloning of the responsible genes, the availability of point mutations will be very important for a more detailed functional analysis. Furthermore, the advances that are currently made in the field of genomics, particularly the production of high resolution genetic, physical and transcript maps will reduce the difficulties inherent in the cloning of the genes mutated after ENU treatment. - ENU mutagenises premeiotic spermatogonia of F males which can be bred to produce a large number of F offspring or F pedigrees, respectively. 0 L 3 • Rev. sci. tech. Off. int. Epiz., 17 (1) 360 Les leçons de l'invalidation de gènes N. Osterrieder & E. W o l f Résumé Les a u t e u r s d é c r i v e n t la t e c h n i q u e d e r e c o m b i n a i s o n h o m o l o g u e a p p l i q u é e a u x c e l l u l e s s o u c h e s e m b r y o n n a i r e s , t r è s utilisée a u j o u r d ' h u i p o u r o b t e n i r d e s souris « k n o c k o u t » d o n t c e r t a i n s g è n e s s p é c i f i q u e s o n t é t é é l i m i n é s . Ils p r é s e n t e n t une s y n t h è s e d e s c o n n a i s s a n c e s sur la p a t h o g é n i e d e s i n f e c t i o n s p a r a s i t a i r e s , b a c t é r i e n n e s ou v i r a l e s , qui se sont multipliées c e s d e r n i è r e s a n n é e s , à partir de r e c h e r c h e s e f f e c t u é e s a v e c d e s souris « k n o c k o u t » , e t sur la r é s i s t a n c e à c e s i n f e c t i o n s . Ils m e t t e n t n o t a m m e n t l ' a c c e n t s u r l e s a n i m a u x « k n o c k o u t » d é p o u r v u s d e c e r t a i n e s c o m p o s a n t e s du r é s e a u d e s c y t o k i n e s e t d e c e r t a i n s g è n e s i m p o r t a n t s pour u n e b o n n e p r é s e n t a t i o n d e s a n t i g è n e s o u d o n t les d i f f é r e n t e s s o u s - p o p u l a t i o n s de c e l l u l e s du s y s t è m e i m m u n i t a i r e p r é s e n t e n t d e s d é f i c i e n c e s . Les a u t e u r s p r é s e n t e n t é g a l e m e n t un bref e x p o s é s u r les possibilités d'induire d e s d é l é t i o n s ou d e s m u t a t i o n s c i b l é e s d a n s l e s g è n e s d ' e s p è c e s a n i m a l e s ( p a r e x e m p l e , p a r t r a n s f e r t n u c l é a i r e ou p a r m u t a g e n è s e à l'aide de l'alkylant N - e t h y l - N - n i t r o s o u r é e ) qui p o u r r a i e n t p e r m e t t r e d e s é l e c t i o n n e r , à l'avenir, d e s a n i m a u x g é n é t i q u e m e n t r é s i s t a n t s a u x m a l a d i e s i n f e c t i e u s e s . Mots-clés Bactéries - Bovins - Cytokines - Génétique - Mutagenèse - Parasites - Souris « knockout » - Virus. Enseñanzas de las supresiones específicas de genes (gene knockouts) N. Osterrieder & E. W o l f « Resumen Los a u t o r e s d e s c r i b e n la t é c n i c a p a r a a p l i c a r la r e c o m b i n a c i ó n h o m ó l o g a en células primordiales embrionarias, actualmente genética para crear e s p e c í f i c a s (knockouts) ratones portadores de m u y utilizada e n i n g e n i e r í a determinadas supresiones d e g e n e s . El artículo c o n t i e n e un r e s u m e n d e los c o n o c i m i e n t o s s o b r e la p a t o g é n e s i s d e las i n f e c c i o n e s p a r a s i t a r i a s , b a c t e r i a n a s o v í r i c a s y la r e s i s t e n c i a a t a l e s i n f e c c i o n e s q u e h a n ido d e p a r a n d o e n los últimos a ñ o s las i n v e s t i g a c i o n e s c o n r a t o n e s m u t a n t e s ( r a t o n e s knockout). Se hace e s p e c i a l h i n c a p i é en los m u t a n t e s d e s p r o v i s t o s d e a l g ú n c o m p o n e n t e d e la r e d de c i t o q u i n a s o d e g e n e s c r u c i a l e s p a r a la c o r r e c t a p r e s e n t a c i ó n d e a n t í g e n o s , y en los q u e s o n d e f i c i e n t e s en a l g u n a s s u b c l a s e s d e c é l u l a s d e l s i s t e m a i n m u n i t a r i o . Se c o m e n t a n a d e m á s s u c i n t a m e n t e las p o s i b i l i d a d e s d e inducir d e l e c i o n e s o m u t a c i o n e s p r e d e f i n i d a s e n d e t e r m i n a d o s g e n e s d e e s p e c i e s g a n a d e r a s (por transferencia nuclear N-etil-N-nitrosourea, o por m u t a g é n e s i s mediante el agente alquilante por e j e m p l o ) , lo q u e haría posible en un f u t u r o la cría selectiva de animales resistentes a e n f e r m e d a d e s infecciosas. Palabras clave Bacterias - Citoquinas - Ganado - Genética - M u t a g é n e s i s - Parásitos «knockout»-Virus. Ratones 361 Rev. sci. tech. Off. int. Epiz., 17(1) References 1. Acton R.D., Dahlberg Fink G.S., Norman J.G. sensitivity to Escherichia necrosis factor p55 or Surg., 131, 1216-1221. P.S., Uknis M.E., Klaemer H.G., & Dunn D.L. (1996). - Differential coli infection in mice lacking tumor interleukin-1 p80 receptors. Arch. 15. Brennan F., Londei M., Jackson A., Hercend T., Brenner M., Maini R. & Feldmann M. (1988). - T-cells expressing yò chain receptoire in rheumatoid arthritis, J. Autoimmun., 1, 139-149. 2. Anderson G.B. (1992). - Isolation and use of embryonic stem cells from livestock species. Anim. Biotech., 3, 165-175. 16. Brown D.R., Swier K., Moskowitz N.H., Naujokas M.F., Locksley R.M. & Reiner S.L. (1997). - T helper subset differentiation in the absence of invariant chain. J. expl Med., 185, 31-41. 3. Bakhiet M., Jansson L., Buscher P., Holmdahl R., Kristensson K. & Olsson T. (1996). - Control of parasitemia and survival during Trypanosoma brucei brucei infection is related to strain-dependent ability to produce IL-4. J. Immunol, 157, 3518-3526. 17. Büeler H., Aguzzi A., Sailer A., Greiner R.A., Autenried P., Aguet M. & Weissmann C. (1993). - Mice devoid of PrP are resistant to scrapie. Cell, 73, 1339-1347. 4. Bakhiet M., Olsson T., Mhlanga J . , Buscher P., Lycke N., van der Meide P.H. & Kristensson K. (1996). - Human and rodent interferon-gamma as a growth factor for Trypanosoma brucei. Eur.J. Immunol, 26, 1359-1364. 5. Baldridge J.R., McGraw T.S., Paoletti A. & Buchmeier M.J. (1997). - Antibody prevents the establishment of persistent arenavirus infection in synergy with endogenous T cells. J. Virol, 7 1 , 755-758. 6. Balling R., Hrabe de Angelis M., Schughart K. & Wolf E. (1998). - We need more mutants: plans for a large-scale ENU mouse mutagenesis screen. OECD, Paris (in press). 7. Berke Z., Wen T., Jin S., Klein G. & Dalianis T. (1995). Polyomavirus persists in CD4/8 double-knockout, but not in CD4 or CD8 single-knockout mice. Virology, 2 1 2 , 268-271. 18. Campbell K.H., McWhir J . , Ritchie W.A. & Wilmut I. (1996). - Sheep cloned by nuclear transfer from a cultured cell line. Nature, 3 8 0 , 64-66. 19. Capecchi M.R. (1989). - Altering the genome homologous recombination. Science, 244, 1288-1292. by 20. Di Giovine F.S. & Duff G.W. (1990). - Interleukin 1: the first interleukin. Immunol. Today, 11, 13-20. 21. DunnD.L. (1991). - Role of endotoxin and host cytokines in septic shock. Chest, 100, 164-168. 22. Epstein S.L., Lo C.Y., Misplon J.A., Lawson C.M., Hendrickson B.A., Max E.E. & Subbarao K. (1997). Mechanisms of heterosubtypic immunity to lethal influenza A vims infection in fully immunocompetent, T cell-depleted, |32-microglobulin-deficient, and J chain-deficient mice. J. Immunol, 158, 1222-1230. 8. Berke Z., Wen T., Klein G. & Dalianis T. (1996). - Polyoma tumor development in neonatally polyoma-virus-infected CD4-/- and CD8-/- single knockout and CD4-/-8-/- double knockout mice. Int. J. Cancer, 67, 405-408. 23. Evans M J . & Kaufman M.H. (1981). - Establishment in culture of pluripotential cells from mouse embryos. Nature, 292, 154-156. 9. Bigazzi P.E. (1996). - A 'nouvelle vague' of animal models: transgenic and knockout mice. Clin. Immunol. Immunopathol, 79, 93-94. 24. Fantuzzi G. & Dinarello C. (1996). - The inflammatory response in interleukin-l beta deficient mice: comparison with other cytokine-related knockout mice. J. Leukoc. Biol., 59, 489-493. 10. Bone R.C. (1993). - Gram-negative sepsis: a dilemma of modem medicine. Clin. Microbiol., 6, 57-68. 11. Bouley D.M., Kanangat S., Wire W. & Rouse B.T. (1995). Characterisation of herpes simplex virus type-l infection and herpetic stromal keratitis development in IFN-gamma knockout mice. J. Immunol, 155, 3964-3971. 12. Bradley A., Evans M., Kaufman M.H. & Robertson E. (1984). - Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature, 3 0 9 , 255-256. 13. Brandon E.P., Idzerda R.L. & McKnight G.S. (1995). Knockouts. Targeting the mouse genome: a compendium of knockouts (Part II). Curr. Biol, 5, 625-634. 14. Brandon E.P., Idzerda R.L. & McKnight G.S. (1995). Targeting the mouse genome: a compendium of knockouts (Part I). Curr. Biol, 5, 873-881. 25. Fâssler R., Martin K., Forsberg E., Litzenburger T. & Iglesias A. (1995). - Knockout mice: How to make them and why. The immunological approach. Int. Arch. Allergy appl. Immunol, 106, 323-334. 26. First N.L., Sims M.M., Park S.P. & Kent First M.J. (1994). Systems for production of calves from cultured bovine embryonic cells. Reprod. Fertil Dev., 6, 553-562. 27. Fong Y. & Lowry S.F. (1990). - Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin. Immunol Immunopathol, 55, 157-170. 28. Franco M.A. & Greenberg H.B. (1995). - Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J. Virol, 69, 7800-7806. 29. Franco M.A., Tin C , Rott L.S., Vancott J.L., McGhee J.R. & Greenberg H.B. (1997). - Evidence for CD8 T cell + 362 ñev. sci. tech. Off. int. Epiz., 17 (1) immunity to murine rotavirus in the absence of perforin, FAS, and gamma interferon. J. Virol., 71, 479-486. 30. Frenkel J.K. (1988). - Pathophysiology of toxoplasmosis. Parasitol Today, 4, 273-289. 31. Gardner R.L. & Brook F.A. (1997). -Reflections on the biology of embryonic stem (ES) cells. Int. J. dev. Biol., 41, 235-243. 32. Gazzinelli R.T., Hieny S., Wynn T., Wolf S. & Sher A. (1993). - I L - 1 2 is required for the T-cell independent induction of IFN-y by an intracellular parasite and induces resistance in T-deficient hosts. Proc. natl Acad. Sci. USA, 90, 6115-6119. 33. Gazzinelli R.T., Wysocka M., Hieny S., Scharton Kersten T., Cheever A., Kuhn R., Muller W., Trinchieri G. & Sher A. (1996). - In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4 T cells and accompanied by overproduction of IL-12, IFN-y and TNF-a. j . Immunol, 157, 798-805. + 34. Graham M., Dalton D., Giltinan D., Braciale V., Stewart T. & Braciale T. (1993). - Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J. expl Med., 178, 1725-1732. 35. Haas W., Pereira P. & Tonegawa S. (1993). - Gamma/delta cells. Annu. Rev. Immunol, 11, 637-685. 36. Hasty P. & Bradley A. (1993). - Gene targeting vectors for mammalian cells. In Gene targeting - a practical approach (A.L. Joyner, ed.). IRL Press, Oxford, New York, Tokyo, •1-31. 37. Haziot A., Ferrero E., Kontgen F., Hijiya N., Yamamoto S., Silver J., Stewart C.L. & Goyert S.M. (1996). - Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice, immunity, 4, 407-414. 38. Heath L , Chrisp C., Huffnagle G., LeGendre M., Osawa Y., Hurley M., Engleberg C., Fantone J. & Brieland J. (1996). -Effector mechanisms responsible for gamma interferon-mediated host resistance to Legionella pneumophila lung infection: the role of endogenous nitric oxide differs in susceptible and resistant murine hosts. Infect. Immun., 64, 5151-5160. 39. Henke A., Huber S., Stelzner A. & Whitton J.L. (1995). - The role of CD8 T lymphocytes in coxsackievirus B3-induced myocarditis.J. Virol, 69, 6720-6728. + 40. Horak I. (1995). -Immunodeficiency in IL-2 knockout mice. Clin. Immunol Immunopathol, 76, 172-173. 41. Hundley J.E., Koester S.K., Troyer D.A., Hilsenbeck S.G., Subler M.A. & Windle J.J. (1997). -Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53. Molec. cell. Biol, 17, 723-731. 42. Hunter C.A., Ellis Neyes L.A., Slifer T., Kanaly S., Grunig G., Fort M., Rennick D. & Araujo F.G. (1997). - I L - 1 0 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi.J. Immunol, 158, 3311-3316. 43. Hwang S.Y., Hertzog P.J., Holland K.A., Sumarsono S.H., Tymms M.J., Hamilton J.A., Whitty G., Bertoncello I. & Kola I. (1995). - A null mutation in the gene encoding a type 1 interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. natl Acad. Sci. USA, 92, 11284-11288. 44. Jiang R. & Gridley T. (1997). - Gene targeting: things go better with Cre. Curr. Biol, 7, 321-323. 45. Jolicoeur P., Masse G. & Kay D.G. (1996). - T h e prion protein gene is dispensable for the development of spongiform myeloencephalopathy induced by the neurovirulent Cas-Br-E murine leukemia virus. J. Virol, 70, 9031-9034. 46. Kaufmann S.H. & Ladel CH. (1994). -Application of knockout mice to the experimental analysis of infections with bacteria and protozoa. Trends. Microbiol, 2, 235-242. 47. Kaufmann S.H. & Ladel C.H. (1994). - Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis BCG. Immunobiology, 191, 509-519. 48. Khan I.A., Matsuura T., .Fonseka S. & Kasper L.H. (1996). - Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice. J. Immunol, 156, 636-643. 49. Kim W.K., Tang Y., Kenny J.J., Longo D.L. & Morse H.C. III (1994). - I n murine AIDS, B cells are early targets of defective virus and are required for efficient infection and expression of defective virus in T cells and macrophages, J. Virol, 68, 6767-6769. 50. Kozak W., Zheng H., Conn C.A., Soszynski D., van der Ploeg L.H. & Kluger M.J. (1995). - Thermal and behavioral effects of lipopolysaccharlde and influenza in interleukin-1 beta-deficient mice. Am. J. Physiol., 2 6 9 , 969-977. 51. Lane T.E., Paoletti A.D. & Buchmeier M.J. (1997). - Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J . Virol, 71, 2202-2210. 52. Lima E.C.S. & Minoprio P. (1996). - Chagas' disease is attenuated in mice lacking yô T cells. Inject. Immun., 64, 215-221. 53. Liu P., Penninger J . , Aitken K., Sole M. & Mak T. (1995). - The role of transgenic knockout models in defining the pathogenesis of viral heart disease. Eur. Heart J., 16 (Suppl), 25-27. 54. Lo D. (1996). -Animal models of human disease. Transgenic and knockout models of autoimmunity: building a better disease? Clin. Immunol. Immunopathol, 79, 96-104. 55. Locksley R.M., Reiner S.L., Hatam F., Littman D.R. & Killeen N. (1993). - Helper T-cells without CD4: control of leishmaniasis in CD4-deficient mice. Science, 2 6 1 , 1448-1451. 363 Rev. sci. tech. Off. int. Epiz., 17 (1) 56. Lowin B., Hahne M., Mattmann C. & Tschopp J . (1994). - Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature, 370, 650-652. 57. Manickan E. & Rouse B.T. (1995). - Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models. J. Virol., 69,8178-8179. 58. Martin G.R. (1981). - Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. natl Acad. Sci. USA, 78, 7634-7638. 59. Matloubian M., Concepcion R.J. & Ahmed R. (1994). - CD4 T cells are required to sustain CD8 cytotoxic T-cell responses during chronic viral infection. J. Virol, 68, 8056-8063. + + 60. Moore K.W., O'Garra R., de Waal Malefyt R., Vieira P. & Mossman T.R. (1997). -Interleukin 10. Annu. Rev. Immunol, 11, 165-190. 61. Murray H.W. (1990). - Effect of continuous administration of interferon-y in experimental visceral leishmaniasis. J. infect. Dis., 161,992-994. 62. Nagy A., Rossant J . , Nagy R., Abramow-Newerly W. & Roder J.C. (1993). -Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. natl Acad. Sci. USA, 9 0 , 8424-8428. 63. Nishinakamura R., Nakayama N , Hirabayashi Y., Inome T., And D., McNeil T., Azuma S., Yoshida S., Toyoda Y. & Arai K. (1995). - Mice deficient for the IL-3/GM-CSF/IL-5 beta 6 receptor exhibit lung pathology and impaired immune response, while beta IL-3 receptor-deficient mice are normal. Immunity, 2, 211-222. 64. Oxenius A., Campbell K.A., Maliszewski C.R., Kishimoto T., Kikutani H., Hengartner H., Zinkernagel R.M. & Bachmann M.F. (1996). - CD40-CD40 ligand interactions are critical in T-B co-operation but not for other anti-viral CD4 T cell functions. J. expl Med., 183, 2209-2218. + 65. Probert L., Akassoglou K., Kassiotis G., Pasparakis M., Alexopoulo L. & Kollias G. (1997). - TNF-a transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol, 72, 137-141. 66. Reiner S.L. & Locksley R.M. (1995). - The regulation of immunity to Leishmania major. Annu. Rev. Immunol, 13, 151-177. 67. Roberts C.W., Ferguson D.J., Jebbari H., Satoskar A., Bluethmann H. & Alexander J . (1996). - Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect Immun., 64, 897-904. 68. Roberts S.J., Smith L.A., West A.B., Wen L , Findly B.C., Owen M.J. & Hayday A.C. (1996). - T-cell a|3 and y ô deficient mice display abnormal but distinct phenotypes toward a natural widespread infection of the intestinal epithelium. Proc. natl Acad. Sci. USA, 9 3 , 11774-11779. + + 69. Rossant J . & Nagy A. (1995). - Genome engineering: the new mouse genetics. Nature Med., 1, 592-594. 70. Rudin W., Favre N., Bordman G. & Ryffel B. (1997). - Interferon-gamma is essential for the development of cerebral malaria. Eur.J. Immunol, 27, 810-815. 71. Sarawar S.R., Cardin R.D., Brooks J.W., Mehrpooya M., Hamilton-Easton A.M., Mo X.Y. & Doherty P.C (1997). - Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68. J. Virol, 7 1 , 3916-3921. 72. Satoskar A., Bluethmann H. & Alexander J . (1995). -Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect. Immun., 63, 4894-4899. 73. Scharton-Kersten T., Caspar P., Sher A. & Denkers E.Y. (1996). - Toxoplasma gondii: evidence for interleukin-12dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain. Expl Parasitol, 84, 102-114. 74. Scharton-Kersten T.M., Wynn T.A., Denkers E.Y., Bala S., Grunvald E., Hieny S., Gazzinelli R.T. & Sher A. (1996). - In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J . immunol., 157, 4045-4054. 75. Scharton-Kersten T.M., Yap G., Magram J. & Sher A. (1997). - Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii, J. expl Med., 185, 1261-1273. 76. Simard C , Klein S.J., Mak T. & Jolicoeur P. (1997). - Studies of the susceptibility of nude, CD4 knockout, and SCID mutant mice to the disease induced by the murine AIDS defective virus. J. Virol, 7 1 , 3013-3022. 77. Smyth M.J., O'Connor M.D. & Trapani J.A. (1996). - Granzymes: a variety of serine protease specificities encoded by genetically distinct subfamilies. J. Leukoc. Biol., 60, 555-562. 78. Sofer Levi Y. & Resnitzky D. (1996). - Apoptosis induced by ectopic expression of cyclin Dl but not cyclin E. Oncogene, 13, 2431-2437. 79. Splitter G., Oliveira S., Carey M., Miller C , Ko J. & Covert J . (1996). - T lymphocyte mediated protection against facultative intracellular bacteria. Vet. Immunol. Immunopathol, 54, 309-319. 80. Squires K.E., Schreiber R.D., McElrath M.J., Rubin B.Y., Anderson S.L. & Murray H.W. (1989). -Experimental visceral leishmaniasis: role of endogenous IFN-y in host defense and tissue granulomatous response. J. Immunol, 143, 4244-4249. 81. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T., Takashima Y., Kawabe Y., Cynshi O., Wada Y., Honda M., 364 Rev. sci. tech. Off. int. Epiz., 17 (1) Kurihara H., Aburatani H., Doi T., Matsumoto A., Azuma S., Noda T., Toyoda Y., Itakura H., Yazaki Y., Horinchi S., Takahashi K., Kruijt J.K., van Berkel T.J.C., Steinbrechev U.P., Ishibashi S., Maeda N., Gordon S. & Kodama T. (1997). - A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature, 386, 292-296. 93. Von der Weid T., Kitamura D., Rajewsky K. & Langhorne J. (1994). - A dual role for B cells in Plasmodium chabaudi (AS) infection? Res. Immunol, 145, 412-419, 82. Suzuki Y., Orellana M.A., Schreiber D. & Remington J.S. (1988). - Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science, 516, 240-243. 95. Walsh C.M., Matloubian M., Liu C.C., Ueda R., Kurahara C.G., Christensen J.L., Huang M.T., Young J.D., Ahmed R. & Clark W.R. (1994). - Immune function in mice lacking the perforin gene. Proc. natl Acad. Sci. USA, 91, 10854-10858. 83. Szalay G., Ladel C.H., Blum C. & Kaufmann S.H. (1996). - IL-4 neutralisation or TNF-alpha treatment ameliorate disease by an intracellular pathogen in IFN-gamma receptor-deficient mice. J. Immunol, 157, 4746-4750. 84. Tang Y., Hugin A.W., Giese N.A., Gabriele L , Chattopadhyay S.K., FredricksonT.N., KagiD., Hartley J.W. & Morse H.C. III (1997). - Control of immunodeficiency and lymphoproliferation in mouse AIDS: studies of mice deficient in CD8 T cells or perforin. J. Virol, 71, 1808-1813. + 85. Tarleton R.L., Grusby M.J., Postan M. & Glimcher L.H. (1996). - Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int. Immunol, 8, 13-22. 86. Taylor A.P. & Murray H.W. (1997). - Intracellular antimicrobial activity in the absence of interferon gamma: effect of interleukin 12 in experimental visceral leishmaniasis in interferon gamma gene disrupted mice. J. expl Med., 185, 1231-1239. 87. Te Riele H., Robanus Maandag E. & Berns A. (1992). - Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc. natl Acad. Sci. USA, 89, 5128-5132. 88. Thomsen A.R., Johansen J., Marker O. & Christensen J.P. (1996). - Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. J. Immunol, 157, 3074-3080. 89. Tishon A., Lewicki H , Rall G., Von Herrath M. & Oldstone M.B. (1995). - An essential role for type 1 interferon-gamma in terminating persistent viral infection. Virology, 212, 244-250. 90. Topham D.J., Tripp R.A., Hamilton Easton A.M., Sarawar S.R. & Doherty P.C. (1996). - Quantitative analysis of the influenza vims-specific CD4 T cell memory in the absence of B cells and Ig. J. Immunol, 157, 2947-2952. + 94. VonderWeidT.,KopfM.,KohlerG. & Langhorne J . (1994). - The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur. J . Immunol, 24, 2285-2293. 96. Wang Z.E., Reiner S.L., Zheng S., Dalton D.K. & Locksley R.M. (1994). - CD4 effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J. expl Med., 179, 1367-1371. + 97. Wang Z.E., Zheng S., Corry D.B., Dalton D.K., Seder R.A., Reiner S.L. & Locksley R.M. (1994). -Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc. natl Acad. Sci. USA, 9 1 , 12932-12936. 98. Wells D.N., Misica P.M., Day T.A.M. & Tervit H.R. (1997). - Production of cloned lambs from an established embryonic cell line: a comparison between in vivo- and in vitro-matured cytoplasts. Biol Reprod., 57, 385-393. 99. Wilmut I., Schnieke A.E., McWhir J., Kind A.J. & Campbell K.H. (1997). - Viable offspring derived from foetal and adult mammalian cells. Nature, 3 8 5 , 810-813. 100. Wolf E., Kramer R., Polejaeva I., Thoenen H. & Brem G. (1994). -Efficient generation of chimaeric mice using embryonic stem cells after long-term culture in the presence of ciliary neurotrophic factor. Transgenic Res., 3, 152-158. 101. Wolf E., Kramer R , Thoenen H. & Brem G. (1994). - Use of oncostatin M for mouse embryonic stem cell culture, Theriogenology, 41, 336. 102. Wolf E., Kramer R., Thoenen H. & Brem G. (1996). - Alternative culture systems for mouse embryonic stem cells. Contrib. Oncol, 5 1 , 214-218. 103. Wood S.A., Allen N.D., Rossant J., Auerbach A. & Nagy A. (1993). - Non-injection methods for the production of embryonic stem cell-embryo chimaeras. Nature, 3 6 5 , 87-89. 104. Yang Y.L., Reis L.F., Pavlovic J . , Aguzzi A., Schafer R., Kumar A., Williams B.R., Aguet M. & Weissmann C. (1995). - Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J., 14, 6095-6106. 105. Yee D., Rhinehart Jones T.R. & Elkins K.L. (1996). - Loss of either CD4 or CD8 T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J. Immunol, 157, 5042-5048. + 91. VanderHeyde H.C., Elloso M.M., Chang W.L., Pepper B.J., Batchelder J. & Weidanz W.P. (1996). - Expansion of the gamma-delta T cell subset in vivo during bloodstage malaria in B cell deficient mice.J. Leukoc. Biol, 60, 221-229. 92. Vikingsson A., Pederson K. & Muller D. (1996). - Altered kinetics of CD4 T cell proliferation and interferon-gamma production in the absence of CD8 T lymphocytes in virus-infected (32-microglobulin-deficient mice. Cell. Immunol, 173, 261-268. + + + 106. Yu Z., Manickan E. & Rouse B.T. (1996). - R o l e of interferon-gamma in immunity to herpes simplex virus. J. Leukoc. Biol, 60, 528-532.